7.31
                                            Precedente Chiudi:
              $7.44
            Aprire:
              $7.36
            Volume 24 ore:
                1.69M
            Relative Volume:
              1.10
            Capitalizzazione di mercato:
                $748.78M
            Reddito:
              $187.64M
            Utile/perdita netta:
              $-95.00M
            Rapporto P/E:
              -7.6947
            EPS:
                -0.95
            Flusso di cassa netto:
                $-69.02M
            1 W Prestazione:
              -2.53%
            1M Prestazione:
              -8.05%
            6M Prestazione:
                -7.82%
            1 anno Prestazione:
              -50.10%
            Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
Nome
                  
                      Day One Biopharmaceuticals Inc
                    
                Settore
                  Industria
                  Telefono
                  
                      650 484-0899
                    
                Indirizzo
                  
                      2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
                    
                Confronta DAWN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                DAWN
                            
                             
                        Day One Biopharmaceuticals Inc 
                           | 
                    7.31 | 762.09M | 187.64M | -95.00M | -69.02M | -0.95 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione | 
|---|---|---|---|
| 2025-08-19 | Iniziato | Piper Sandler | Overweight | 
| 2024-10-09 | Reiterato | Needham | Buy | 
| 2024-08-01 | Aggiornamento | BofA Securities | Underperform → Buy | 
| 2024-04-24 | Reiterato | Needham | Buy | 
| 2023-04-25 | Downgrade | BofA Securities | Buy → Underperform | 
| 2023-02-08 | Iniziato | CapitalOne | Overweight | 
| 2023-02-03 | Iniziato | Oppenheimer | Perform | 
| 2022-12-15 | Iniziato | H.C. Wainwright | Buy | 
| 2022-12-14 | Iniziato | Needham | Buy | 
| 2022-12-05 | Iniziato | Goldman | Buy | 
| 2022-12-01 | Iniziato | BofA Securities | Buy | 
                    Mostra tutto
                    
                  
                Day One Biopharmaceuticals Inc Borsa (DAWN) Ultime notizie
Pattern recognition hints at Day One Biopharmaceuticals Inc. upsideBull Run & Weekly High Potential Stock Alerts - newser.com
Can Day One Biopharmaceuticals Inc. rally from current levelsQuarterly Earnings Report & Technical Entry and Exit Alerts - newser.com
Multi factor analysis applied to Day One Biopharmaceuticals Inc.Insider Selling & Weekly Return Optimization Plans - newser.com
What Wall Street predicts for Day One Biopharmaceuticals Inc. stock priceQuarterly Profit Summary & Expert Verified Movement Alerts - newser.com
Day One Biopharmaceuticals Inc (DAWN) Q3 2025 Earnings Report Pr - GuruFocus
Day One Biopharmaceuticals Inc (DAWN) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Will Day One Biopharmaceuticals Inc. stock remain a Wall Street favoriteEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com
Key resistance and support levels for Day One Biopharmaceuticals Inc.Weekly Trade Report & Community Shared Stock Ideas - newser.com
Will Day One Biopharmaceuticals Inc. stock maintain growth storyJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - newser.com
Market reaction to Day One Biopharmaceuticals Inc.’s recent news2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - newser.com
How Day One Biopharmaceuticals Inc. stock benefits from global expansionForecast Cut & Advanced Technical Analysis Signals - newser.com
Will Day One Biopharmaceuticals Inc. price bounce be sustainableEarnings Overview Report & Community Consensus Stock Picks - newser.com
Will Day One Biopharmaceuticals Inc. stock recover faster than peersWeekly Investment Summary & Stock Timing and Entry Methods - newser.com
Y Intercept Hong Kong Ltd Invests $1.83 Million in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
What Fibonacci levels say about Day One Biopharmaceuticals Inc. reboundJuly 2025 Price Swings & Verified Stock Trade Ideas - newser.com
Applying Wyckoff theory to Day One Biopharmaceuticals Inc. stockJuly 2025 Retail & Capital Efficiency Focused Ideas - newser.com
Day One Biopharmaceuticals Inc expected to post a loss of 29 cents a shareEarnings Preview - TradingView
Day One Biopharmaceuticals (NASDAQ:DAWN) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Day One Biopharmaceuticals Inc. stock outlook for YEARJuly 2025 Price Swings & Advanced Technical Analysis Signals - newser.com
Why Day One Biopharmaceuticals Inc. stock attracts global investors2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com
What does recent volatility data suggest for Day One Biopharmaceuticals Inc.Volume Spike & Verified Chart Pattern Signals - newser.com
Forecasting Day One Biopharmaceuticals Inc. price range with options data2025 Volatility Report & Weekly Top Gainers Trade List - newser.com
Wall Street Analysts See a 234.66% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High? - sharewise.com
Day One Biopharmaceuticals Advances Cancer Treatment with DAY301 Study - MSN
Day One Biopharmaceuticals Inc Azioni (DAWN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):